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DOI 10.1016/j.stem.2009.07.001To our knowledge, for the first time, we
demonstrate that induced pluripotent
stem cells (iPSCs) can autonomously
generate full-termmice via tetraploid blas-
tocysts complementation. Differentiated
somatic cells can be reprogrammed into
iPSCs by forced expression of four tran-
scription factors—Oct4, Sox2, Klf4, and
c-Myc. However, it has been unclear
whether reprogrammed iPSCs are fully
pluripotent, resembling normal embryonic
stem cells (ESCs), as no iPSC lines have
shown the ability to autonomously
generate full-term mice after injection into
tetraploid blastocysts. Here we provide
evidence demonstrating that an iPSC line
induced by the four transcription factors
can be used to generate full-term mice
fromcomplemented tetraploid blastocysts
and thus appears to be fully pluripotent.
This work serves as a proof of principle
that iPSCs can in fact generate full-term
embryos by tetraploid complementation.
Reprogramming of differentiated so-
matic cells into iPSCs via expression of
four defined transcription factors has at-
tracted great scientific and public atten-
tion, and the generation of iPSCs from
individual patients has raised hopes for
treating many degenerative and genetic
diseases (Dimos et al., 2008; Ebert et al.,
2009; Hanna et al., 2007; Park et al., 2008;
Soldner et al., 2009; Takahashi et al., 2007;
Takahashi and Yamanaka, 2006; Wernig
et al., 2008; Yu et al., 2007). iPSCs can
functionally differentiate into all cell line-
ages within chimeric mice, including
germ cells that can ultimately give rise to
offspring (Maherali et al., 2007; Okita et al.,
2007; Takahashi and Yamanaka, 2006;
Wernig et al., 2007). However, unlike ESCs
or even somatic cell nuclear transfer
(SCNT)-produced NT-ESCs, no iPSC lines
have so far fulfilled the most stringent
pluripotency criterion of being able to
generate full-term mice via tetraploid
blastocyst complementation (Hayashi andSurani, 2009; Jaenisch, 2008; Maherali
and Hochedlinger, 2008; Wernig et al.,
2007). To understand the reprogramm-
ing mechanisms that occur during iPSC
generation, it is important to address
whether iPSCs are fully pluripotent.
As in previous reports (Brambrink et al.,
2008; Stadtfeld et al., 2008), doxycycline
(Dox)-controlled Tet-on-inducible lentivi-
ruses carrying cDNAs of the transcription
factors Oct4, Sox2, Klf4, and c-Myc were
transduced into mouse embryonic fibro-
blast (MEF) cells from ROSA26-M2rtTA
transgenic mice (Figure 1A). After viral
transduction, the MEFs were cultured in
ES culture medium containing Dox for 12
days until ES-like colonies appeared,
and then the Dox was removed from the
culture medium (Figure 1B). Four days
later, ES-like colonies were individually
digested and replated in 24-well plates.
After propagation, we selected five
iPSC lines that exhibited typical ESC
morphology (Figure 1C) for long-term
culture and characterization. The ES-like
colonies generated were positive for AP
activity (see Figure S1 available online).
RT-PCR and qPCR analysis demon-
strated that the expression of pluripotency
marker genes, including Oct4, Sox2, and
Nanog, was comparable across all five
iPSC lines and normal ESC lines but
showed dramatic differences relative to
MEFs (Figures 1D and 1E). Silencing of the
exogenous lentiviral vectors was also
observed (Figure S2). Immunofluorescent
staining further confirmed the protein
expression of three transcription factors
and the surface marker SSEA-1 in the
iPSCs (Figure 1F). In addition, other pluri-
potency-related geneswere all expressed
at similar levels in the iPSCs and normal
ESCs (Figure S3). The karyotypes of all
five iPSC lines were normal, with 40 chro-
mosomes (Figure S4). Southern blot anal-
ysis was used to examine viral integration
into the genome of iPSCs and indicatedCell Stem Cethat there were one or two integrations
for each of the four lentiviral constructs
into the iPS genome (Figure 1G).
To investigate the pluripotency of the
generated iPSCs, we performed in vitro
differentiation and teratoma and chimera
experiments. The iPSCs formed EBs effi-
ciently in vitro, and upregulation of marker
genes for all three germ layers was de-
tected in the plated EBs (Figure S5). We
then transplanted the iPSCs subcutane-
ously into immune-deficient SCID mice
and found that all the iPSC lines tested
generated teratomas 3–4 weeks after
transplantation. Hematoxylin and eosin
(H&E) staining indicated that the iPSCs
could differentiate into a variety of cell
types from all three germ layers (Fig-
ure 1H). The LiPS-6 line generated post-
natal chimeras with normal appearance
that gave rise to germline offspring after
mating with ICR female mice (Figure 1I).
However, we could not produce full-term
mice from this line via tetraploid comple-
mentation. Meanwhile, we noticed a very
high degree of chimerism in the chimeras
generated from one iPSC line, LiPS-8, as
indicated by its chimera coat color, which
was almost completely contributed by
iPSC (Figure 1J). We therefore decided to
test whether these iPSCs were capable
of generating full-termmice through tetra-
ploid complementation.
We first generated tetraploid embryos
by fusing late two-cell-stage embryos to
one-cell-stage embryos using an Electro
Cell Manipulator (BTX 2001). The embryos
were collected from B6D2F1 female mice
mated with male mice of the same strain.
Ten to fifteen iPSCs were microinjected
into the cavity of tetraploid blastocysts,
and the complemented blastocysts (n =
200) were transferred into seven pseudo-
pregnant ICR female mice after 2–3 hr of
recovery. On the due date, a C-section
was performed to ascertain whether any
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in Figure 2A, we produced two full-term
mice from the iPSC-complemented tetra-
ploid blastocysts. One pup (Figure 2Ab)
was overweight (2.72 g) and died within
1 hr following the C-section. The other
pup (Figure 2Aa) was of normal weight
(1.36 g) and survived for 3 days but died
because the surrogate mother refused to
feed it. To test whether the fully iPSC-
derived mouse can survive to adulthood,
we repeated this experiment with tetra-
ploid blastocysts from ICR mice. After
transplantation of 187 tetraploid-comple-
mented blastocysts into the oviducts of
sevenpseudopregnantmice,wesuccess-
fully produced two more full-term pups
from these embryos (Figure 2A), and one
pup survived into adulthood and appears
to be healthy (Figure 2B). The efficiency
of generating full-term mice from iPSC-
complemented ICR tetraploid embryos
was similar to the B6D2F2 background
embryos (1.07%versus1.00%,Figure2F).
We then performed SSLP and rtTA anal-
ysis of the organs collected from the three
dead pups and the tail tip of the live
mouse. The results clearly indicated that
all the pups were derived from the iPSCs
(mostly C57BL/6 background) and not
from the tetraploid embryos (B6D2F2 or
ICR background) (Figures 2C–2E). More-
over, we successfully cultured skin fibro-
blast cells from the pups that died shortly
after the C-section. After adding Dox to
Figure 1. Generation of Inducible iPSCs and
Characterization
(A) Morphology of MEF cells collected from
ROSA26-M2rtTA transgenic mice.
(B) Colonies formed after infection and Dox
induction.
(C) Morphology of iPSCs after propagation.
(D) RT-PCR revealed that inducible iPSCs
expressed ESC marker genes including OCT4,
SOX2, and NANOG.
(E) qPCR revealed that the expression level of ESC
marker genes in iPSCswas similar to that of normal
ESCs.
(F) Immunofluorescent staining results demon-
strated that the iPSCs were positive for OCT4,
SOX2, NANOG, and SSEA-1. Scale bars, 20 mm.
(G) Southern blot analysis showed that there were
one or two integrations for each virus into the iPS
genome.
(H) Teratomas formed 4 weeks after injection of
iPSCs into SCID mice. Tissues of the three germ
layers were detected by H&E staining.
(I) The chimeric mouse showed germline transmis-
sion capability.
(J) High chimerism (>90%) was found in the
chimeric mice produced from a particular iPSC
line (LiPS-8).
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Figure 2. Generation of iPS-Tetraploid Mice
(A) Four pups were produced autonomously from iPSCs complemented with tetraploid blastocysts
collected from either B6D2F1 mice or ICR mice. One pup from iPS-B6D2F1 tetraploid complementation
died 3 days after C-section because the surrogate mother refused feeding (Aa), one overweight pup from
iPS-B6D2F1 tetraploid complementation died (Ab), one pup from iPS-ICR tetraploid complementation
died shortly after C-section (Ac), and one pup from iPS-ICR tetraploid complementation survived (Ad).
(B) The pup (Ad) generated from iPS-ICR tetraploid complementation grows into an adult.
(C) SSLP analysis of organs of three dead tetraploid-complemented pups (Aa–Ac). D6Mit15 and
D11Mit236 were used.
(D) Genomic PCR analyzed the transgene, rtTA, in the organs of three dead tetraploid-complemented
pups.
(E) Genomic PCR and SSLP were performed to analyze the live adult mouse derived from iPS-tetraploid
complementation. Transgene rtTA and D11Mit236 were analyzed, respectively.
(F) Efficiency of generation of iPSC-tetraploid-complemented pups. The efficiency is lower than the
efficiency of using normal B6D2F1 ESCs (Table S1).
(G) Scatter plots comparing global gene expression patterns between iPSCs and ESCs (left), between
iPSCs and MEFs (middle), and between R1 and MEFs (right), as determined by DNA microarray. ‘‘R’’ indi-
cates Pearson correlation coefficient, and the lines indicate 2-fold changes in gene expression levels
between the samples.
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peared (Figure S6), and the efficiency
was substantially higher than for the first
round of iPS induction. As the inducible
iPSC line LiPS-8 is, to our knowledge,
the first iPSC line that has been used
successfully to generate mice by tetra-
ploid complementation, we investigated
the gene expression profile of this partic-
ular cell line as compared with the normal
ESC lines, R1, and the parental MEF cells.
The data clearly showed that the gene
expression profile of this specific iPS line
is very similar to the normal ESCs (Fig-
ure 2G). Meanwhile, bisulfite genomic
DNA sequencing analysis of the Oct4
promoter showed that it is highly unme-
thylated in the inducible iPSC line LiPS-8,
whereas it is highly methylated in the
parental MEF cells (Figure S7).
In conclusion, we have successfully
produced full-term mice from iPSC-
complemented tetraploid blastocysts.
Although these findings are an important
proof of principle, it would be premature
to make claims based on them about
whether iPSCs in general are functionally
equivalent to normal ESCs, as we have
here only identified one iPSC line that
possesses this capacity, and the process
is also very inefficient. It is possible that
this line has specific characteristics that
allow tetraploid-complementation activity
but are not shared by other iPSC lines. It
will be interesting to evaluate whether
iPSCs generated using fewer factors or
different approaches are capable of pro-
ducing tetraploid-complemented mice
(Kim et al., 2008, 2009; Nakagawa et al.,
2008) to assist with advancing overall
understanding of the molecular mecha-
nisms involved in iPSC generation. More-
over, partial reprogramming could poten-
tially provide an explanation for the
inefficient differentiation of iPSCs into
certain cell lineages, and obtaining more
fully reprogrammed iPSCs in humans
might facilitate directed differentiation of
iPSCs into ideal cell types.
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